Skip to main content

Table 3 Calculated resectability vs. evaluated resectability

From: Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial

 

Surgeon A

Surgeon B

Surgeon C

Surgeon D

Surgeon E

Agreement between Surgeon and ISGP

76.1%

83.4%

74.1%

72.9%

79.8%

Disagreement

23.9%

16.6%

25.9%

27.1%

20.2%

Surgeon

ISGP

 

Resectable

Locally advanced

1.0%

1.0%

1.3%

2.6%

4.6%

Resectable

Borderline resectable

7.3%

3.5%

13.9%

18.8%

9.6%

Locally advanced

Resectable

0.5%

2.5%

0%

0%

0%

Locally advanced

Borderline resectable

0%

0%

1.9%

0.5%

0%

Undetermined

Resectable

6.8%

2.5%

2.5%

1.6%

2.0%

Undetermined

Locally advanced

8.3%

7.1%

6.3%

3.6%

4.0%

  1. Resectability was calculated from the single items assessed by the 5 surgeons according to ISGPS recommendations. The resectability calculated from the assessment of tumor abutment to peripancreatic vascular structures was compared to the judgement of resectability given by the evaluating surgeon